<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04884230</url>
  </required_header>
  <id_info>
    <org_study_id>UnidadInternacional</org_study_id>
    <nct_id>NCT04884230</nct_id>
  </id_info>
  <brief_title>Oversewing Staple Line of The Gastric Remnant</brief_title>
  <official_title>Oversewing Staple Line of the Gastric Remnant in Gastric Bypass Reduces Postoperative Bleeding.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unidad Internacional de Cirugia Bariatrica y Metabolica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Unidad Internacional de Cirugia Bariatrica y Metabolica</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Roux-en-Y gastric bypass (RYGB) is a surgery with low rate complications.&#xD;
      However, it is not exempt from them, and 1-6% suffer complications such as postoperative&#xD;
      bleeding. Many intraoperative techniques have been evaluated to reduce postoperative&#xD;
      bleeding, like the oversewing or reinforcement of the staple line. This study aims to&#xD;
      evaluate the rate of postoperative bleeding in the oversewing of the staple line of the&#xD;
      gastric remnant group versus the stapling only group.&#xD;
&#xD;
      Methods: This is a 2-center, case-control study. The investigators randomly selected two&#xD;
      groups who underwent RYGB or OAGB: group A (n=225) with oversewing from 2019-2020 and group B&#xD;
      (n=225) with stapling only between the period of 2017-2018; both groups with similar&#xD;
      demographic characteristics.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This case-control study was conducted in the International Unit of Bariatric and Metabolic&#xD;
      Surgery of &quot;Clinica La Sagrada Familia&quot; located in Maracaibo, Venezuela, and in &quot;Grupo Medico&#xD;
      Santa Paula&quot; Caracas, Venezuela. All procedures were performed by a single experienced&#xD;
      bariatric surgeon during the period 2017-2020. The Ethics committees of Clinica &quot;La Sagrada&#xD;
      Familia&quot; and &quot;Grupo Medico Santa Paula&quot; approved this study. The investigators selected 225&#xD;
      patients (group A) from the period 2019-2020 where the stapling line of the gastric remnant&#xD;
      was oversewn and another group of 225 patients (group B) from the period of 2017-2018 with&#xD;
      stapling alone.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 5, 2017</start_date>
  <completion_date type="Actual">May 5, 2020</completion_date>
  <primary_completion_date type="Actual">February 5, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Reduce bleeding</measure>
    <time_frame>Through study completion, 6 month average</time_frame>
    <description>assessing melena</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">250</enrollment>
  <condition>Gastric Bypass</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <description>We selected 225 patients (group A) from the period 2019-2020 where the stapling line of the gastric remnant was oversewn and another group of 225 patients (group B) from the period of 2017-2018 with stapling alone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <description>We selected 225 patients (group A) from the period 2019-2020 where the stapling line of the gastric remnant was oversewn and another group of 225 patients (group B) from the period of 2017-2018 with stapling alone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oversewing</intervention_name>
    <description>Oversewing of the gastric remnant</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients older than 18 years, body mass index (BMI) &gt; 30kg/m2 with or without comorbidities&#xD;
        that underwent RYGB or one anastomosis gastric bypass (OAGB).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Our inclusion criteria were patients older than 18 years, body mass index (BMI) &gt;&#xD;
             30kg/m2 with or without comorbidities that underwent RYGB or one anastomosis gastric&#xD;
             bypass (OAGB).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  We exclude from our study any patient with psychiatric disorder, open surgery history,&#xD;
             history of previous bariatric surgery, non-controlled comorbidity at the moment of&#xD;
             surgery, and patients under the age of 18&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CCSF</name>
      <address>
        <city>MAracaibo</city>
        <state>Zulia</state>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Venezuela</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 3, 2021</study_first_submitted>
  <study_first_submitted_qc>May 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2021</study_first_posted>
  <last_update_submitted>May 6, 2021</last_update_submitted>
  <last_update_submitted_qc>May 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Unidad Internacional de Cirugia Bariatrica y Metabolica</investigator_affiliation>
    <investigator_full_name>Andres Maldonado</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Personal.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

